April 01, 2025

Daily Physical Activity—Even at Light Intensities—May Reduce Cancer Risk

Investigators evaluated the risk of cancer among individuals who engaged in light- and moderate-to-vigorous–intensity physical activity daily.

The ASCO Post

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant

March 31, 2025

Clopidogrel Outshines Aspirin After PCI

“In our study, clopidogrel beat aspirin as a lifelong maintenance monotherapy after standard-duration dual antiplatelet therapy."

Conexiant

March 31, 2025

Hormone Therapy Boosts Semaglutide Weight Loss

At 12 months, women on hormone therapy achieved 16% total body weight loss with semaglutide, compared to 12% in those not using hormone therapy, researchers reported.

Conexiant

March 28, 2025

T2D: Non-traditional CVD Risk Factors

Investigators identify and rank non-traditional risk factors for cardiovascular disease prediction.

Conexiant

March 28, 2025

AID Improves Glucose Control in Type 2 Diabetes, Study Shows

Automated insulin delivery (AID) reduced glycated hemoglobin by 0.9 percentage points in adults with type 2 diabetes, compared to 0.3 points in those who used continuous glucose monitoring methods alone.

Conexiant

March 27, 2025

Trends in Spironolactone Prescribing Among Young Women

A cohort study of 38 million insured females aged 12 to 40 years found a marked increase in spironolactone prescriptions, most commonly for acne and other androgen-related conditions.

Conexiant

March 27, 2025

Education Level Linked to Poststroke Decline

Researchers found that stroke survivors with higher education levels experienced faster poststroke decline in executive function despite better initial cognitive performance.

Conexiant